stars 1 stars 2 stars 3

BioLens is a free catalyst radar for biotech and pharma. It follows what happens to a drug on its way to patients: the trial results, the FDA filing, the expert panel, and the FDA decision (PDUFA) date. For every company you follow, you see what is coming next, which drug it is about, and how far along that drug is. Each event comes with its source, a link to the trial record or the company filing, and a clear label when a date is still an estimate. When a decision or a result comes in, the outcome is recorded next to it. BioLens also publishes independent research on individual companies: the science, the pipeline, the risks and what would prove the view wrong. Every note is written before the outcome is known and scored afterwards in an open track record. No account needed. Your list stays in your browser, and an optional free account syncs it across devices. Built by Thomas Bouman. Not financial advice.

Website https://bio-lens.net/
Employees 1 (1 on RocketReach)
Founded 2026
Industry Financial Services

BioLens Questions

Thomas Bouman is the Founder of BioLens.

1 people are employed at BioLens.

Top BioLens Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users